"Perphenazine/pharmacokinetics"[Mesh Terms:noexp] - Search Results

Year	Number of Results
1988	1
1989	2
1990	1
1991	2
1992	1
1993	3
1994	2
1996	2
1997	2
1998	1
1999	1
2000	1
2001	1
2007	2
2008	1
2009	3
2010	4
2011	1
2013	1
2024	0

1

Population pharmacokinetics of perphenazine in schizophrenia patients from CATIE: impact of race and smoking.

Jin Y, Pollock BG, Coley K, Miller D, Marder SR, Florian J, Schneider L, Lieberman J, Kirshner M, Bies RR. Jin Y, et al. J Clin Pharmacol. 2010 Jan;50(1):73-80. doi: 10.1177/0091270009343694. Epub 2009 Oct 20. J Clin Pharmacol. 2010. PMID: 19843655 Free PMC article. Clinical Trial.

2

Pharmacologic profile of perphenazine's metabolites.

Sweet RA, Pollock BG, Mulsant BH, Rosen J, Sorisio D, Kirshner M, Henteleff R, DeMichele MA. Sweet RA, et al. J Clin Psychopharmacol. 2000 Apr;20(2):181-7. doi: 10.1097/00004714-200004000-00010. J Clin Psychopharmacol. 2000. PMID: 10770456

3

BL-1020, an oral antipsychotic agent that reduces dopamine activity and enhances GABAA activity, for the treatment of schizophrenia.

Fitzgerald PB. Fitzgerald PB. Curr Opin Investig Drugs. 2010 Jan;11(1):92-100. Curr Opin Investig Drugs. 2010. PMID: 20047163 Review.

4

Fast-dissolving sublingual solid dispersion and cyclodextrin complex increase the absorption of perphenazine in rabbits.

Turunen E, Mannila J, Laitinen R, Riikonen J, Lehto VP, Järvinen T, Ketolainen J, Järvinen K, Jarho P. Turunen E, et al. J Pharm Pharmacol. 2011 Jan;63(1):19-25. doi: 10.1111/j.2042-7158.2010.01173.x. Epub 2010 Nov 16. J Pharm Pharmacol. 2011. PMID: 21155811

5

Disposition of perphenazine is related to polymorphic debrisoquin hydroxylation in human beings.

Dahl-Puustinen ML, Lidén A, Alm C, Nordin C, Bertilsson L. Dahl-Puustinen ML, et al. Clin Pharmacol Ther. 1989 Jul;46(1):78-81. doi: 10.1038/clpt.1989.109. Clin Pharmacol Ther. 1989. PMID: 2743709

6

Perphenazine in breast milk and serum.

Olesen OV, Bartels U, Poulsen JH. Olesen OV, et al. Am J Psychiatry. 1990 Oct;147(10):1378-9. doi: 10.1176/ajp.147.10.1378. Am J Psychiatry. 1990. PMID: 2400007 No abstract available.

7

Pharmacokinetics of orally disintegrating tablets of perphenazine/hydroxypropyl-beta-cyclodextrin inclusion complex in rabbits.

Wang L, Xiao YY, Chen ML, Zeng F, Zong L. Wang L, et al. Pharmazie. 2013 Oct;68(10):800-4. Pharmazie. 2013. PMID: 24273883

8

An evaluation of linearity of kinetics for the neuroleptics perphenazine and zuclopenthixol.

Linnet K. Linnet K. Eur J Clin Pharmacol. 1997;52(4):317-8. Eur J Clin Pharmacol. 1997. PMID: 9248772 No abstract available.

9

BL-1020: a novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia.

Geffen Y, Nudelman A, Gil-Ad I, Rephaeli A, Huang M, Savitsky K, Klapper L, Winkler I, Meltzer HY, Weizman A. Geffen Y, et al. Eur Neuropsychopharmacol. 2009 Jan;19(1):1-13. doi: 10.1016/j.euroneuro.2008.07.002. Epub 2008 Aug 30. Eur Neuropsychopharmacol. 2009. PMID: 18757185

10

Perphenazine distribution in a postmortem case.

Levine B, Jenkins A, Chute D, Smialek JE. Levine B, et al. J Anal Toxicol. 1999 Mar-Apr;23(2):127-9. doi: 10.1093/jat/23.2.127. J Anal Toxicol. 1999. PMID: 10192418

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year